藥 物 回 收
|
| |
| The United Kingdom: Class 2 Medicines Recall: Fucidin 250 mg Tablets, LEO Laboratories Ltd trading as LEO Pharma (English only) |
| |
Medicines and Healthcare products Regulatory Agency (MHRA) announces that LEO Pharma is recalling one batch of Fucidin 250 mg Tablets (sodium fusidate) (batch number: D00993) as a precautionary measure due to out of specification results for impurities during routine stability testing.
The product is indicated in the treatment of all staphylococcal infections due to susceptible organisms such as cutaneous infections, osteomyelitis, pneumonia, septicaemia, wound infections, endocarditis, superinfected cystic fibrosis.
Please refer to the following website in MHRA for details:
http://www.gov.uk/drug-device-alerts/class-2-medicines-recall-fucidin-250-mg-tablets-leo-laboratories-ltd-trading-as-leo-pharma-el-25-a-slash-38
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Wednesday, Aug 6, 2025
Issued at HKT 15:15
|
| |
|
